Advanced pharmaceutical bulletin最新文献

{"title":"Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells.","authors":"Ali Akbar Alizadeh,&nbsp;Saba Rasouli,&nbsp;Omid Jamshidi Kandjani,&nbsp;Salar Hemmati,&nbsp;Siavoush Dastmalchi","doi":"10.34172/apb.2023.064","DOIUrl":"https://doi.org/10.34172/apb.2023.064","url":null,"abstract":"<p><strong>Purpose: </strong>Teduglutide is the first and only FDA-approved drug for long-term treatment of short bowel syndrome (SBS). The current study aimed to present an approach for production of teduglutide using recombinant DNA technology.</p><p><strong>Methods: </strong>The coding gene for teduglutide was cloned into pGEX-2T vector, where coding sequence for factor Xa cleavage site was added between GST and teduglutide coding genes. The GST-teduglutide protein was overexpressed in <i>E. coli</i> BL21 (DE3) strain and affinity purified using glutathione sepharose affinity column.</p><p><strong>Results: </strong>On-column proteolytic activity of factor Xa followed by size exclusion chromatography resulted in the pure teduglutide. Circular dichroism (CD) spectropolarimetry showed that the produced teduglutide folds into mainly α-helical structure (>50%), as expected. In mass spectroscopy analysis, the fragments of teduglutide resulted by cyanogen bromide cleavage as well as those expected theoretically due to mass fragmentation were identified. The functionality of the produced peptide was evaluated by measuring its proliferative effect on Caco2 intestinal epithelial cells, and the results indicated that produced teduglutide induces cell proliferation by 19±0.30 and 33±7.82 % at 1.21 and 3.64 µM concentrations, respectively, compared to untreated cells.</p><p><strong>Conclusion: </strong>Teduglutide was successfully expressed and purified and its functionality and structural integrity were confirmed by <i>in vitro</i> experiments. We believe that the experimental-scale method presented in the current study can be useful for pilot-scale and also industrial-scale production of teduglutide.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Designing Potent Anticancer Peptides by Aurein 1.2 Key Residues Mutation and Catenate Cell-Penetrating Peptide.","authors":"Hamta Salarpour Garnaie,&nbsp;Arman Shahabi,&nbsp;Mohammad Hossein Geranmayeh,&nbsp;Abolfazel Barzegar,&nbsp;Ahmad Yari Khosroushahi","doi":"10.34172/apb.2023.063","DOIUrl":"https://doi.org/10.34172/apb.2023.063","url":null,"abstract":"<p><strong>Purpose: </strong>Aurein 1.2 (Aur) peptide is known for possessing anticancer characteristics devoid of conventional therapeutics side effects. For improving Aur peptide anticancer functionality, different anticancer peptides were constructed based on Aur peptide through targeting two separate strategies, including (1) sequence-based mutations and (2) adding a cell-penetrating peptide linker.</p><p><strong>Methods: </strong>The study was approached by designing three different analogs of Aur, including (a) Aur mutant (Aur_m), (b) Aur with N-terminal polyarginine linker (R5-Aur), and (c) Aur_m with R5 (R5-Aur_m). Computational molecular dynamics simulations clearly showed higher structural stability of R5-Aur and R5-Aur_m compared to Aur, solely. The α-helical properties of R5-Aur and R5-Aur_m were protected during 500 ns simulations in water solution while no such structural conservation was seen for Aur <i>in silico</i>.</p><p><strong>Results: </strong>The results of the current study highlight response to one of the main challenges of cancer therapy through selective invasion of Aur to cancer cells without significant involvement of normal cells. This issue was confirmed by different assays, including: MTT assay, flow cytometry, qPCR, and nuclei morphological observations. Furthermore, this study intensifies exploiting <i>in silico</i> approaches for adjusting drug delivery. The results of different assessments on designed peptides reveal an anticancer activity pattern rising from Aur toward Aur_m, and R5- Aur, consecutively.</p><p><strong>Conclusion: </strong>The designed structure of Aur shows improved anticancer activity through molecular changes which makes it suggestable for anticancer therapies.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigating the Effect of Basic Amino Acids and Glucosamine on the Solubility of Ibuprofen and Piroxicam.","authors":"Hadi Valizadeh,&nbsp;Somayeh Mahdinloo,&nbsp;Negin Zakeri,&nbsp;Muhammad Sarfraz,&nbsp;Saeed Nezafat,&nbsp;Parvin Zakeri-Milani","doi":"10.34172/apb.2023.067","DOIUrl":"https://doi.org/10.34172/apb.2023.067","url":null,"abstract":"<p><strong>Purpose: </strong>Poor aqueous solubility hampers the development of several compounds as pharmacological agents. Hence, preparing novel formulations with augmented absorption is a challenge in pharmaceutical industries. In this paper, we have examined the effect of basic amino acids including arginine (ARG), lysine (LYS), and glucosamine (GlucN) on the solubility of ibuprofen (IBU) and piroxicam (PXM) as drugs with limited solubility. We have also studied the effect of the dissolution media with the pH values 1.2 to 7.4.</p><p><strong>Methods: </strong>The saturation shake-flask method was used for solubility studies in the presence of amino acids. Briefly, buffer solutions containing different concentrations of amino acids were prepared. Then, an excess amount of each drug with these buffers was shaken to reach equilibrium. After 48 hours, the upper phase was separated, and solubility was calculated by reading their UV-Vis absorbance.</p><p><strong>Results: </strong>The results illustrated that amino acids increased solubility of both drugs with different ratios, which were pH and concentration-dependent. Solubility improved as the amount of amino acids went up, and this upward pattern was more robust with ARG than LYS. The presence of GlucN in citrate buffer significantly enhanced IBU solubility. The solubility of PXM in accompany of GlucN in water did not change significantly while in citrate buffer solubility enhanced specially at pH 6.</p><p><strong>Conclusion: </strong>Overall, GlucN in citrate buffer and ARG in phosphate buffer could be introduced as the most suitable media for IBU and PXM solubility improvement, respectively.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat.","authors":"Fatemeh Yaghoobizadeh,&nbsp;Mohammad Roayaei Ardakani,&nbsp;Mohammad Mehdi Ranjbar,&nbsp;Mohammad Khosravi,&nbsp;Hamid Galehdari","doi":"10.34172/apb.2023.059","DOIUrl":"https://doi.org/10.34172/apb.2023.059","url":null,"abstract":"<p><strong>Purpose: </strong>Among all known human coronaviruses, some viruses (e.g., SARS-CoV-2) cause severe pneumonia or even death. With the regard to its spread and the importance of its rapid identification/treatment, and because pAbs are relatively cheap, able to bind to more sites on antigens and even neutralize them, this study was done for the production and purification of anti-SARS-CoV-2 polyclonal antibodies (pAb) in rats.</p><p><strong>Methods: </strong>Viral antigen purification was performed by PEG/NaCl precipitation. The efficiency of the sucrose cushion method was also investigated to produce a purer antigen. Immunization was done and antibody purification was performed by ammonium sulfate precipitation (33%), dialysis, and ion-exchange chromatography. Western blotting and enzyme-linked immunosorbent assay (ELISA) were performed to verify the antibody specificity. All data were analyzed by SPSS software.</p><p><strong>Results: </strong>The results showed that the amount of concentrated virus increased with the increase of PEG concentration. Moreover, the sucrose cushion method increased its purity. Besides, induction of immune response in rats for pAb production with high titers was reached via these antigens and ELISA/western blot results indicated a suitable antibody-antigen interaction. Additionally, it was shown that ion-exchange chromatography could be a suitable technique for IgG purification.</p><p><strong>Conclusion: </strong>Herein, we presented a simple and cheap method for the purification of whole viral particles with relatively high quality. The results verified that these antigens could elicit a good immune response in the rat. The obtained pAbs showed a good specificity toward SARS-CoV-2 antigens. Accordingly, this study proposes a promising method for viral vaccine development.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10176428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"MicroRNAs and Periodontal Disease: Helpful Therapeutic Targets?","authors":"Abdolhakim Palideh,&nbsp;Mostafa Vaghari-Tabari,&nbsp;Ali Nosrati Andevari,&nbsp;Durdi Qujeq,&nbsp;Zatollah Asemi,&nbsp;Forough Alemi,&nbsp;Hemmatollah Rouhani Otaghsara,&nbsp;Sona Rafieyan,&nbsp;Bahman Yousefi","doi":"10.34172/apb.2023.048","DOIUrl":"https://doi.org/10.34172/apb.2023.048","url":null,"abstract":"<p><p>Periodontal disease is the most common oral disease. This disease can be considered as an inflammatory disease. The immune response to bacteria accumulated in the gum line plays a key role in the pathogenesis of periodontal disease. In addition to immune cells, periodontal ligament cells and gingival epithelial cells are also involved in the pathogenesis of this disease. miRNAs which are small RNA molecules with around 22 nucleotides have a considerable relationship with the immune system affecting a wide range of immunological events. These small molecules are also in relation with periodontium tissues especially periodontal ligament cells. Extensive studies have been performed in recent years on the role of miRNAs in the pathogenesis of periodontal disease. In this review paper, we have reviewed the results of these studies and discussed the role of miRNAs in the immunopathogenesis of periodontal disease comprehensively. miRNAs play an important role in the pathogenesis of periodontal disease and maybe helpful therapeutic targets for the treatment of periodontal disease.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10176426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation.","authors":"Arsalan Jalili,&nbsp;Abbas Hajifathali,&nbsp;Mozhdeh Mohammadian,&nbsp;Ghazaleh Sankanian,&nbsp;Maryam Sayahinouri,&nbsp;Mahmoud Dehghani Ghorbi,&nbsp;Elham Roshandel,&nbsp;Nasser Aghdami","doi":"10.34172/apb.2023.046","DOIUrl":"https://doi.org/10.34172/apb.2023.046","url":null,"abstract":"<p><p>Hematopoietic stem cell transplantation (HSCT) is a life-saving therapy for various hematologic disorders. Due to the bone marrow suppression and its long recovery period, secondary infections, like cytomegalovirus (CMV), Epstein-Bar virus (EBV), and adenovirus (AdV), are the leading causes of morbidity and mortality in HSCT cases. Drug resistance to the antiviral pharmacotherapies makes researchers develop adoptive T cell therapies like virus-specific T cell therapy. These studies have faced major challenges such as finding the most effective T cell expansion methods, isolating the expected subtype, defining the functionality of the end-cell population, product quality control, and clinical complications after the injection. This review discusses the viral infections after HSCT, T cells characteristics during chronic viral infection, application of virus-specific T cells (VSTs) for refractory infections, standard methods for producing VSTs and their limitation, clinical experiences on VSTs, focusing on outcomes and side effects that can be helpful in decision-making for patients and further researches.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19.","authors":"Elnaz Shaseb,&nbsp;Saba Ghaffary,&nbsp;Alireza Garjani,&nbsp;Elnaz Zoghi,&nbsp;Nasrin Maleki Dizaji,&nbsp;Somaieh Soltani,&nbsp;Parvin Sarbakhsh,&nbsp;Mohammad Hossein Somi,&nbsp;Parya Valizadeh,&nbsp;Ali Taghizadieh,&nbsp;Masood Faghihdinevari,&nbsp;Mojtaba Varshochi,&nbsp;Behrooz Naghily,&nbsp;Zhinous Bayatmakoo,&nbsp;Parviz Saleh,&nbsp;Sepehr Taghizadeh,&nbsp;Mehdi Haghdoost,&nbsp;Hamid Owaysi,&nbsp;Fatemeh Ravanbakhsh Ghavghani,&nbsp;Mohammad Kazem Tarzamni,&nbsp;Rojin Moradi,&nbsp;Fateme Javan Ali Azar,&nbsp;Saeid Shabestari Khiabani,&nbsp;Ardavan Ghazanchaei,&nbsp;Sana Hamedani,&nbsp;Shahabeddin Hatefi","doi":"10.34172/apb.2023.066","DOIUrl":"https://doi.org/10.34172/apb.2023.066","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of the study is to evaluate the effect of metformin in complication improvement of hospitalized patients with COVID-19.</p><p><strong>Methods: </strong>This was a randomized clinical trial that involved 189 patients with confirmed COVID-19 infection. Patients in the intervention group received metformin-500 mg twice daily. Patients who received metformin before admission were excluded from the control group. Patients who were discharged before taking at least 2000 mg of metformin were excluded from the study. Primary outcomes were vital signs, need for ICU admission, need for intubation, and mortality.</p><p><strong>Results: </strong>Data showed that patients with diabetes with previous metformin in their regimen had lower percentages of ICU admission and death in comparison with patients without diabetes (11.3% vs. 26.1% (<i>P</i>=0.014) and 4.9% vs. 23.9% (<i>P</i>≤0.001), respectively). Admission time characteristics were the same for both groups except for diabetes and hyperlipidemia, which were significantly different between the two groups. Observations of naproxen consumption on endpoints, duration of hospitalization, and the levels of spO₂ did not show any significant differences between the intervention and the control group. The adjusted OR for intubation in the intervention group versus the control group was 0.21 [95% CI, 0.04-0.99 (<i>P</i>=0.047)].</p><p><strong>Conclusion: </strong>In this trial, metformin consumption had no effect on mortality and ICU admission rates in non-diabetic patients. However, metformin improved COVID-19 complications in diabetic patients who had been receiving metformin prior to COVID-19 infection, and it significantly lowered the intubation rates.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optimization of a Self-microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat.","authors":"Shahla Mirzaeei,&nbsp;Negar Tahmasebi,&nbsp;Ziba Islambulchilar","doi":"10.34172/apb.2023.054","DOIUrl":"https://doi.org/10.34172/apb.2023.054","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to formulate Resveratrol, a practically water-insoluble antioxidant in a self-microemulsifying drug delivery system (SMEDDS) to improve the solubility, release rate, and intestinal permeability of the drug.</p><p><strong>Methods: </strong>The suitable oil, surfactant, and co-surfactant were chosen according to the drug solubility study. Utilizing the design of experiment (DoE) method, the pseudo-ternary phase diagram was plotted based on the droplet size. <i>In vitro</i> dissolution study and the single-pass intestinal perfusion were performed for the investigation of <i>in vitro</i> and <i>in-situ</i> permeability for drugs formulated as SMEDDS in rat intestine using High-Performance Liquid Chromatography.</p><p><strong>Results: </strong>Castor oil, Cremophor^® RH60, and PEG 1500 were selected as oil, surfactant, and co-surfactant. According to the pseudo-ternary phase diagram, nine formulations developed microemulsions with sizes ranging between 145-967 nm. Formulations passed the centrifuge and freeze-thaw stability tests. The optimum formulation possessed an almost 2.5-fold higher cumulative percentage of <i>in vitro</i> released resveratrol, in comparison to resveratrol aqueous suspension within 120 minutes. The results of the <i>in-situ</i> permeability study suggested a 2.6-fold higher intestinal permeability for optimum formulation than that of the resveratrol suspension.</p><p><strong>Conclusion: </strong>SMEDDS can be considered suitable for the oral delivery of resveratrol according to the observed increased intestinal permeability, which could consequently enhance the bioavailability and therapeutic efficacy of the drug.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases.","authors":"Jafar Sadeghzadeh,&nbsp;Parviz Shahabi,&nbsp;Mehdi Farhoudi,&nbsp;Abbas Ebrahimi-Kalan,&nbsp;Ahmad Mobed,&nbsp;Kourosh Shahpasand","doi":"10.34172/apb.2023.061","DOIUrl":"https://doi.org/10.34172/apb.2023.061","url":null,"abstract":"<p><p>Tau protein plays a crucial role in diagnosing neurodegenerative diseases. However, performing an assay to detect tau protein on a nanoscale is a great challenge for early diagnosis of diseases. Enzyme-linked immunosorbent assay (ELISA), western-blotting, and molecular-based methods, e.g., PCR and real-time PCR, are the most widely used methods for detecting tau protein. These methods are subject to certain limitations: the need for advanced equipment, low sensitivity, and specificity, to name a few. With the above said, it is necessary to discover advanced and novel methods for monitoring tau protein. Counted among remarkable approaches adopted by researchers, biosensors can largely eliminate the difficulties and limitations associated with conventional methods. The main objective of the present study is to review the latest biosensors developed to detect the tau protein. Furthermore, the problems and limitations of conventional diagnosis methods were discussed in detail.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells.","authors":"Seyed Sadegh Eslami,&nbsp;Davod Jafari,&nbsp;Abbas Ghotaslou,&nbsp;Moein Amoupour,&nbsp;Amir Asri Kojabad,&nbsp;Rasool Jafari,&nbsp;Navid Mousazadeh,&nbsp;Parastoo Tarighi,&nbsp;Majid Sadeghizadeh","doi":"10.34172/apb.2023.050","DOIUrl":"https://doi.org/10.34172/apb.2023.050","url":null,"abstract":"<p><strong>Purpose: </strong>Chemotherapy drugs used to treat lung cancer are associated with drug resistance and severe side effects. There have been rising demands for new therapeutic candidates and novel approaches, including combination therapy. Here, we aimed to investigate the combinatorial effect of a dendrosomal formulation of curcumin (DNC) and daunorubicin (DNR) on the A549 lung cancer cell line.</p><p><strong>Methods: </strong>We performed cytotoxicity, apoptosis, cell migration, colony-formation capacity, and gene expression analysis to interpret the mechanism of action for a combination of DNC and DNR on A549 cells.</p><p><strong>Results: </strong>Our results revealed that the combination of DNC and DNR could synergistically inhibit the A549 cells' growth. This synergistic cytotoxicity was further approved by flow cytometry, migration assessment, colony-forming capacity and gene expression analysis. DNR combination with DNC resulted in increased apoptosis to necrosis ratio compared to DNR alone. In addition, the migration and colony-forming capacity were at the minimal range when DNC was combined with DNR. Combined treatment decreased the expression level of <i>MDR-1, hTERT</i> and <i>Bcl-2</i> genes significantly. In addition, the ratio of <i>Bax/Bcl2</i> gene expression significantly increased. Our analysis by free curcumin, dendrosomes and DNC also showed that dendrosomes do not have any significant cytotoxic effect on the A549 cells, suggesting that this carrier has a high potential for enhancing the curcumin's biological effects.</p><p><strong>Conclusion: </strong>Our observations suggest that the DNC formulation of curcumin synergistically enhances the antineoplastic effect of DNR on the A549 cell line through the modulation of apoptosis/necrosis ratio, as well as <i>Bax/Bcl2</i> ratio, <i>MDR-1</i> and <i>hTERT</i> gene expression.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10176423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}